ERYTECH Provides Business and Financial Update for the First Quarter of 2022 Post author:Marianne Duparc Post published:May 12, 2022 Post category:Newsroom ERYTECH Pharma provided a business and financial update at the end of March 2022. You Might Also Like ERYTECH Presents New Preclinical Data on ERY-MET at the 2017 ASCO GI Symposium January 17, 2017 ERYTECH appoints Dr. Iman El-Hariry as Chief Medical Officer July 15, 2015 ERYTECH Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Patients July 21, 2021